{"transactions":[{"id":885098,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T23:44:57.000Z","date":"2026-02-20","kind":"grant","planned":true,"acquired":true,"shares":123000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed"}],"balance_after":337392,"source":{"system":"sec-edgar","filing":"0001094891-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000109489126000070/form4.xml","form_type":"4"}},{"id":1253077,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-21T22:28:46.000Z","date":"2025-02-20","kind":"grant","planned":true,"acquired":true,"shares":112800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed"}],"balance_after":214392,"source":{"system":"sec-edgar","filing":"0001062993-25-003193","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299325003193/form4.xml","form_type":"4"}},{"id":1622724,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2024-02-23T21:48:00.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025."}],"balance_after":150000,"derivative":{"exercise_price":1.23,"expiration_date":"2034-02-22","underlying":"Common stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001062993-24-004285","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299324004285/form4.xml","form_type":"4"}},{"id":1772648,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-09-28T00:53:53.000Z","date":"2023-09-26","kind":"sale","planned":true,"acquired":false,"shares":9747,"price":1.45,"value":14133.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."}],"balance_after":101592,"source":{"system":"sec-edgar","filing":"0001062993-23-018552","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323018552/form4.xml","form_type":"4"}},{"id":1772647,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-09-28T00:53:53.000Z","date":"2023-09-26","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":1.43,"value":14300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."}],"balance_after":111339,"source":{"system":"sec-edgar","filing":"0001062993-23-018552","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323018552/form4.xml","form_type":"4"}},{"id":1772646,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-09-28T00:53:53.000Z","date":"2023-09-26","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":1.474,"value":14740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."}],"balance_after":121339,"source":{"system":"sec-edgar","filing":"0001062993-23-018552","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323018552/form4.xml","form_type":"4"}},{"id":1772645,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-09-28T00:53:53.000Z","date":"2023-09-25","kind":"sale","planned":true,"acquired":false,"shares":200,"price":1.43,"value":286.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."}],"balance_after":131339,"source":{"system":"sec-edgar","filing":"0001062993-23-018552","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323018552/form4.xml","form_type":"4"}},{"id":1772644,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-09-28T00:50:14.000Z","date":"2023-09-21","kind":"sale","planned":true,"acquired":false,"shares":100,"price":1.44,"value":144.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."}],"balance_after":131539,"source":{"system":"sec-edgar","filing":"0001062993-23-018551","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323018551/form4a.xml","form_type":"4/A","original_submission_date":"2023-09-22"}},{"id":1772643,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-09-28T00:50:14.000Z","date":"2023-09-20","kind":"sale","planned":true,"acquired":false,"shares":412,"price":1.44,"value":593.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."}],"balance_after":131639,"source":{"system":"sec-edgar","filing":"0001062993-23-018551","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323018551/form4a.xml","form_type":"4/A","original_submission_date":"2023-09-22"}},{"id":1772642,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-09-28T00:50:14.000Z","date":"2023-09-20","kind":"sale","planned":true,"acquired":false,"shares":3405,"price":1.45,"value":4937.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."}],"balance_after":132051,"source":{"system":"sec-edgar","filing":"0001062993-23-018551","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323018551/form4a.xml","form_type":"4/A","original_submission_date":"2023-09-22"}},{"id":1774684,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-09-22T22:39:39.000Z","date":"2023-09-21","kind":"sale","planned":false,"acquired":false,"shares":100,"price":1.44,"value":144.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023."}],"balance_after":131539,"source":{"system":"sec-edgar","filing":"0001062993-23-018421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323018421/form4.xml","form_type":"4"}},{"id":1774683,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-09-22T22:39:39.000Z","date":"2023-09-20","kind":"sale","planned":false,"acquired":false,"shares":412,"price":1.44,"value":593.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023."}],"balance_after":131639,"source":{"system":"sec-edgar","filing":"0001062993-23-018421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323018421/form4.xml","form_type":"4"}},{"id":1774682,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-09-22T22:39:39.000Z","date":"2023-09-20","kind":"sale","planned":false,"acquired":false,"shares":3405,"price":1.45,"value":4937.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023."}],"balance_after":132051,"source":{"system":"sec-edgar","filing":"0001062993-23-018421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323018421/form4.xml","form_type":"4"}},{"id":2036365,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2023-02-03T01:39:29.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023."}],"balance_after":175000,"derivative":{"exercise_price":1.31,"expiration_date":"2033-01-31","underlying":"Common stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001062993-23-002038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299323002038/form4.xml","form_type":"4"}},{"id":2152751,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-09-22T15:46:51.000Z","date":"2022-09-20","kind":"sale","acquired":false,"shares":16864,"price":1.7,"value":28668.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed."}],"balance_after":135456,"source":{"system":"sec-edgar","filing":"0001062993-22-019850","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299322019850/form4.xml","form_type":"4"}},{"id":2152750,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-09-22T15:46:51.000Z","date":"2022-09-20","kind":"sale","acquired":false,"shares":17000,"price":1.7067,"value":29013.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed."}],"balance_after":152320,"source":{"system":"sec-edgar","filing":"0001062993-22-019850","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299322019850/form4.xml","form_type":"4"}},{"id":2378840,"issuer":{"id":6375,"kind":"organization","name":"Lucid Diagnostics Inc."},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2022-02-24T01:23:16.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":59000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 quarterly installments, with first installment vesting March 31, 2022."}],"balance_after":59000,"derivative":{"exercise_price":3.95,"expiration_date":"2032-02-18","underlying":"Common stock","underlying_shares":59000},"source":{"system":"sec-edgar","filing":"0001062993-22-005490","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799011/000106299322005490/form4.xml","form_type":"4"}},{"id":3491334,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T16:30:36.000Z","date":"2019-06-11","kind":"sale","acquired":false,"shares":9000,"price":1.44,"value":12960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2019, to cover payment of tax liability incident to the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.46. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53010,"source":{"system":"sec-edgar","filing":"0000899243-19-016822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924319016822/doc4.xml","form_type":"4"}},{"id":3494232,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-11T18:23:02.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable in 12 substantially equal monthly installments commencing June 7, 2019."}],"balance_after":22000,"derivative":{"exercise_price":1.54,"expiration_date":"2029-06-07","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000899243-19-016463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924319016463/doc4.xml","form_type":"4"}},{"id":3494231,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-11T18:23:02.000Z","date":"2019-06-08","kind":"exercise","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 8, 2018 the reporting person was granted 9,000 restricted stock units that vested on June 8, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 8, 2018 the reporting person was granted 9,000 restricted stock units that vested on June 8, 2019."}],"balance_after":9000,"derivative":{"underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-19-016463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924319016463/doc4.xml","form_type":"4"}},{"id":3494230,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-11T18:23:02.000Z","date":"2019-06-08","kind":"exercise","acquired":true,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":62010,"source":{"system":"sec-edgar","filing":"0000899243-19-016463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924319016463/doc4.xml","form_type":"4"}},{"id":3770569,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-08T14:05:47.000Z","date":"2018-11-06","kind":"exercise","acquired":false,"shares":27058,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2012-08-20","expiration_date":"2019-01-16","underlying":"Common Stock","underlying_shares":27058},"source":{"system":"sec-edgar","filing":"0000899243-18-028518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924318028518/doc4.xml","form_type":"4"}},{"id":3770568,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T14:05:47.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":6048,"price":5.29,"value":31993.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.27 to $5.33. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53010,"source":{"system":"sec-edgar","filing":"0000899243-18-028518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924318028518/doc4.xml","form_type":"4"}},{"id":3770567,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T14:05:47.000Z","date":"2018-11-06","kind":"exercise","acquired":true,"shares":27058,"price":1.16,"value":31387.28,"ownership":{"direct":true},"balance_after":59058,"source":{"system":"sec-edgar","filing":"0000899243-18-028518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924318028518/doc4.xml","form_type":"4"}},{"id":3896807,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-12T11:40:27.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on June 8, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on June 8, 2019."}],"balance_after":9000,"derivative":{"underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-18-016142","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924318016142/doc4.xml","form_type":"4"}},{"id":3905323,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-05T16:42:59.000Z","date":"2017-06-02","kind":"exercise","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 2, 2017 the reporting person was granted 18,000 RSUs that vested on June 2, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 2, 2017 the reporting person was granted 18,000 RSUs that vested on June 2, 2018."}],"balance_after":18000,"derivative":{"underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000899243-18-015110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924318015110/doc4.xml","form_type":"4"}},{"id":3905322,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T16:42:59.000Z","date":"2018-06-05","kind":"sale","acquired":false,"shares":6000,"price":8.87,"value":53220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold to cover payment of tax liability incident to the vesting of RSUs originally granted to the reporting person on June 2, 2017."}],"balance_after":32000,"source":{"system":"sec-edgar","filing":"0000899243-18-015110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924318015110/doc4.xml","form_type":"4"}},{"id":3905321,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T16:42:59.000Z","date":"2018-06-02","kind":"exercise","acquired":true,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":38000,"source":{"system":"sec-edgar","filing":"0000899243-18-015110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000089924318015110/doc4.xml","form_type":"4"}},{"id":4288410,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-08T16:15:16.000Z","date":"2017-06-06","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27058,"derivative":{"exercise_price":1.16,"exercise_date":"2012-08-20","expiration_date":"2019-01-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-17-038155","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000110465917038155/a4.xml","form_type":"4"}},{"id":4288409,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-08T16:15:16.000Z","date":"2017-06-06","kind":"exercise","acquired":true,"shares":20000,"price":1.16,"value":23200.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-17-038155","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000110465917038155/a4.xml","form_type":"4"}},{"id":4291066,"issuer":{"id":11728,"kind":"organization","name":"T2 Biosystems, Inc.","symbol":"TTOO"},"owners":[{"id":64961,"kind":"person","name":"Lapidus Stanley","position":1,"cik":"0001678195","reported_name":"Lapidus Stanley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-06T11:57:12.000Z","date":"2017-06-02","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on June 2, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on June 2, 2018."}],"balance_after":18000,"derivative":{"underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-17-037649","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492674/000110465917037649/a4.xml","form_type":"4"}}]}